Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis

Study Identifier
Olo-keto/2009
CT.gov Identifier
NCT01258309
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Allergy
  • Conjunctivitis
    • Study Drug
  • olopatadine hydrochloride /ketorolac tromethamine fixed dose combination ophthalmic solution
  • olopatadine hydrochloride 0.1% ophthalmic solution
    • Phase
    Phase 3
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Clinical diagnosis of seasonal allergic conjunctivitis
    Exclusion Criteria:
    * Ocular infection or history of ocular herpes infection * History of retinal detachment or diabetic retinopathy * Prior or current use of systemic or topical steroids, NSAIDs, anticholinergics, immunosuppressants, or antihistamines * Ocular surgery within 8 weeks

    Protocol Summary

    This study will investigate the safety and efficacy of olopatadine hydrochloride / ketorolac tromethamine fixed dose combination ophthalmic solution compared with olopatadine hydrochloride ophthalmic solution in patients with seasonal allergic conjunctivitis.

    Study Locations

    Location
    Status
    Location
    Bangalore, Karnataka, India
    Status
    Not applicable